metricas
covid
Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Influence of HLA-G polymorphism in antibody response to hepatitis B vaccination ...
Journal Information
Vol. 21. Issue 2.
Pages 76-81 (July - December 2020)
Share
Share
Download PDF
More article options
Vol. 21. Issue 2.
Pages 76-81 (July - December 2020)
Original article
Influence of HLA-G polymorphism in antibody response to hepatitis B vaccination during the first year of life
Influencia del polimorfismo HLA-G en la respuesta de anticuerpos a la vacuna frente a la hepatitis B durante el primer año de vida
A.A. El Shahawaya,
Corresponding author
aliaabdelmonem@yahoo.com

Corresponding author.
, A.A. Ahmedb, M.A. Arafac, M.M. Maleka
a Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
b Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
c Pediatrics Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Baseline characteristics of the participants.
Table 2. Association of HLA-G 14bp polymorphism with response to the HB vaccine.
Table 3. Distribution of anti-HBs titer (IU/mL) according to genotypes in responder and non-responder groups.
Show moreShow less
Abstract
Objective

This research intended to evaluate the antibody response to vaccination against hepatitis B during the first year of life. We also aimed to assess the association between the antibody response to hepatitis B vaccination and the polymorphism in HLA-G 14bp.

Material and methods

In this comparative cross-sectional study, 93 infants that received the hepatitis B vaccine at 2, 4, and 6 months old according to the World Health Organization immunization schedules, were evaluated for their antibodies to HBsAg (anti-HBs) following vaccination. Their genomic DNA was extracted and examined for the polymorphism in HLA-G 14bp by PCR.

Results

Among 93 vaccinated infants, 11 infants (11.8%) were non-responders to vaccination against hepatitis B (anti-HBs<10IU/mL). The mean antibody titers for responders and non-responders were 77.65±27.14IU/mL and 4.45±2.38IU/mL, respectively. The 14-bp insertion allele was associated with an increased risk of failure o respond to hepatitis B vaccination (OR 3.72, 95% CI 1.32–10.6).

Conclusion

This study reported, for the first time, that ins/ins genotype may be a risk factor for non-responsiveness to hepatitis B vaccination.

Keywords:
Hepatitis B Vaccination
Humoral immunity
HLA-G 14bp in/del
Infants
Resumen
Objetivo

El objetivo de este estudio fue evaluar la respuesta de anticuerpos a la vacuna frente a la hepatitis B durante el primer año de vida. También tratamos de evaluar la asociación entre la respuesta de anticuerpos a la vacuna frente a la hepatitis B y el polimorfismo en HLA-G 14bp.

Material y métodos

En este estudio transversal comparativo se evaluó el HBsAg (anti-HBS) de 93 niños que recibieron la vacuna contra la hepatitis B a los 2, 4 y 6 meses de edad, conforme a los programas de la Organización Mundial de la Salud, fueron evaluados por sus anticuerpos frente a HBsAg (anti-HBs) después de la vacunación. Se extrajo su ADN genómico. examinándose el polimorfismo en HLA-G 14bp mediante la prueba PCR.

Resultados

Entre los 93 niños vacunados, 11 niños (11,8%) no respondieron a la vacuna frente a la hepatitis B (anti-HBs<10UI/mL). Los títulos de anticuerpos medios para respondedores y no respondedores fueron de 77,65±27,14 y 4,45±2,38UI/mL, respectivamente. El alelo 14bp inserción se asoció a un incremento del riesgo de fallo de respuesta a la vacuna frente a la hepatitis B (OR: 3,72; IC 95%: 1,32-10,6).

Conclusión

Este estudio reportó, por vez primera, que el genotipo ins/ins puede constituir un factor de riesgo para la no respuesta a la vacuna frente a la hepatitis B.

Palabras clave:
Vacunación contra la hepatitis B
Inmunidad humoral
HLA-G 14bp in / del
Lactantes

Article

These are the options to access the full texts of the publication Vacunas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Vacunas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos